Cagri- 5mg
 
Cagrilintide is a medication that combines two hormones, amylin and glucagon-like peptide-1 (GLP-1), to treat obesity and type 2 diabetes. Its potential benefits include: 
Weight Loss:
Cagrilintide promotes satiety and reduces appetite, leading to significant weight loss in individuals with obesity and overweight. Studies have shown that it can induce weight loss of up to 15% in a year. 
Improved Blood Sugar Control:
By stimulating insulin secretion and suppressing glucagon release, cagrilintide helps regulate blood sugar levels in people with type 2 diabetes. This can improve glycemic control and reduce the risk of complications associated with diabetes. 
Reduced Cardiovascular Risk:
Weight loss and improved blood sugar control can contribute to a lower risk of cardiovascular events, such as heart attack and stroke. 
Enhanced Metabolic Health:
Cagrilintide can improve insulin sensitivity, reduce body fat, and lower cholesterol levels, leading to overall better metabolic health. 
Improved Sleep Quality:
Some studies suggest that cagrilintide may improve sleep quality in individuals with obesity and metabolic disorders. 
Synergy with GLP-1 Agonists:
When combined with GLP-1 agonists, such as semaglutide, cagrilintide can provide even greater weight loss and metabolic benefits.